436 related articles for article (PubMed ID: 23247231)
21. Supraglottic laryngeal cancer: analysis of treatment results.
Sessions DG; Lenox J; Spector GJ
Laryngoscope; 2005 Aug; 115(8):1402-10. PubMed ID: 16094113
[TBL] [Abstract][Full Text] [Related]
22. Treatment, comorbidity and survival in stage III laryngeal cancer.
Connor KL; Pattle S; Kerr GR; Junor E
Head Neck; 2015 May; 37(5):698-706. PubMed ID: 24596316
[TBL] [Abstract][Full Text] [Related]
23. Life after total laryngectomy: a measure of long-term survival, function, and quality of life.
Woodard TD; Oplatek A; Petruzzelli GJ
Arch Otolaryngol Head Neck Surg; 2007 Jun; 133(6):526-32. PubMed ID: 17576901
[TBL] [Abstract][Full Text] [Related]
24. National trends in laryngeal cancer surgery and the effect of surgeon and hospital volume on short-term outcomes and cost of care.
Gourin CG; Frick KD
Laryngoscope; 2012 Jan; 122(1):88-94. PubMed ID: 22052419
[TBL] [Abstract][Full Text] [Related]
25. Predictors of outcome for advanced-stage supraglottic laryngeal cancer.
Ganly I; Patel SG; Matsuo J; Singh B; Kraus DH; Boyle J; Wong RJ; Lee N; Pfister DG; Shaha AR; Shah JP
Head Neck; 2009 Nov; 31(11):1489-95. PubMed ID: 19408292
[TBL] [Abstract][Full Text] [Related]
26. Comorbid predictors of poor response to chemoradiotherapy for laryngeal squamous cell carcinoma.
Hu M; Ampil F; Clark C; Sonavane K; Caldito G; Nathan CA
Laryngoscope; 2012 Mar; 122(3):565-71. PubMed ID: 22252981
[TBL] [Abstract][Full Text] [Related]
27. Oncologic outcomes in advanced laryngeal squamous cell carcinomas treated with different modalities in a single institution: a retrospective analysis of 65 cases.
Bussu F; Miccichè F; Rigante M; Dinapoli N; Parrilla C; Bonomo P; Cadoni G; Mantini G; Galli J; Rufini V; Almadori G; Valentini V; Paludetti G
Head Neck; 2012 Apr; 34(4):573-9. PubMed ID: 21692130
[TBL] [Abstract][Full Text] [Related]
28. Occult nodal disease in patients with failed laryngeal preservation undergoing surgical salvage.
Koss SL; Russell MD; Leem TH; Schiff BA; Smith RV
Laryngoscope; 2014 Feb; 124(2):421-8. PubMed ID: 24323309
[TBL] [Abstract][Full Text] [Related]
29. Short- and long-term outcomes of laryngeal cancer care in the elderly.
Gourin CG; Starmer HM; Herbert RJ; Frick KD; Forastiere AA; Eisele DW; Quon H
Laryngoscope; 2015 Apr; 125(4):924-33. PubMed ID: 25367258
[TBL] [Abstract][Full Text] [Related]
30. Management of T3N0M0 glottic carcinoma: therapeutic outcomes.
Sessions DG; Lenox J; Spector GJ; Newland D; Simpson J; Haughey BH; Chao KS
Laryngoscope; 2002 Jul; 112(7 Pt 1):1281-8. PubMed ID: 12169914
[TBL] [Abstract][Full Text] [Related]
31. The effect of treatment on survival in patients with advanced laryngeal carcinoma.
Gourin CG; Conger BT; Sheils WC; Bilodeau PA; Coleman TA; Porubsky ES
Laryngoscope; 2009 Jul; 119(7):1312-7. PubMed ID: 19444887
[TBL] [Abstract][Full Text] [Related]
32. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
[TBL] [Abstract][Full Text] [Related]
33. Disparities in stage at diagnosis among adults with testicular germ cell tumors in the National Cancer Data Base.
Lerro CC; Robbins AS; Fedewa SA; Ward EM
Urol Oncol; 2014 Jan; 32(1):23.e15-21. PubMed ID: 23395701
[TBL] [Abstract][Full Text] [Related]
34. Elective neck dissection for no neck during salvage total laryngectomy: findings, complications, and oncological outcome.
Basheeth N; O'Leary G; Sheahan P
JAMA Otolaryngol Head Neck Surg; 2013 Aug; 139(8):790-6. PubMed ID: 23949354
[TBL] [Abstract][Full Text] [Related]
35. Comorbidity measurement in patients with laryngeal squamous cell carcinoma.
Castro MA; Dedivitis RA; Ribeiro KC
ORL J Otorhinolaryngol Relat Spec; 2007; 69(3):146-52. PubMed ID: 17264530
[TBL] [Abstract][Full Text] [Related]
36. Effect of body mass index on chemoradiation outcomes in head and neck cancer.
McRackan TR; Watkins JM; Herrin AE; Garrett-Mayer EM; Sharma AK; Day TA; Gillespie MB
Laryngoscope; 2008 Jul; 118(7):1180-5. PubMed ID: 18475213
[TBL] [Abstract][Full Text] [Related]
37. Use of potentially curative therapies for muscle-invasive bladder cancer in the United States: results from the National Cancer Data Base.
Gray PJ; Fedewa SA; Shipley WU; Efstathiou JA; Lin CC; Zietman AL; Virgo KS
Eur Urol; 2013 May; 63(5):823-9. PubMed ID: 23200811
[TBL] [Abstract][Full Text] [Related]
38. Disparities in the allocation of treatment in advanced ovarian cancer: are there certain patient characteristics associated with nonstandard therapy?
Chase DM; Fedewa S; Chou TS; Chen A; Ward E; Brewster WR
Obstet Gynecol; 2012 Jan; 119(1):68-77. PubMed ID: 22183213
[TBL] [Abstract][Full Text] [Related]
39. Concurrent chemoradiation therapy with docetaxel (DOC) for laryngeal preservation in T2N0M0 glottic squamous cell carcinomas.
Furusaka T; Matsuda A; Saito T; Katsura Y; Ikeda M
Acta Otolaryngol; 2013 Jan; 133(1):99-112. PubMed ID: 23106412
[TBL] [Abstract][Full Text] [Related]
40. The association of insurance and stage at diagnosis among patients aged 55 to 74 years in the national cancer database.
Ward EM; Fedewa SA; Cokkinides V; Virgo K
Cancer J; 2010; 16(6):614-21. PubMed ID: 21131794
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
